Immunotherapy: MAPK‐Targeted Drug Delivered by a pH‐Sensitive MSNP Nanocarrier Synergizes With PD‐1 Blockade in Melanoma Without T‐Cell Suppression (Adv. Funct. Mater. 12/2019)

Advanced Functional Materials - United Kingdom
doi 10.1002/adfm.201970079

Related search